hme

What’s new and on the horizon for patients with CLL?

An interview with Prof Stephan Stilgenbauer (duration 11:30)



In this podcast, Professor Stilgenbauer will evaluate how ongoing research into CLL disease biology may impact clinical management in the future and the potential of novel treatment approaches.

 

Learning objective:

After listening to this podcast you should be able to:

  • Review ongoing research into CLL disease biology and the novel treatment options being developed for patients with this disease 

 

Faculty:

  • Stephan Stilgenbauer (Germany)

 

More Info
12 Minutes
EM-66690 - Date of preparation: August 2021